StockOtters
StockOttersSupply Chain Map
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited

1093.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
3,840
Cost of Revenue
1,153
Gross Profit
2,687
Gross Margin
70.0%
Operating Income
709
Operating Margin
18.5%
Net Income
573
Net Margin
14.9%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
933
EBITDA Margin
24.3%

2023

12/31/2023

Revenue
4,091
Cost of Revenue
1,206
Gross Profit
2,885
Gross Margin
70.5%
Operating Income
911
Operating Margin
22.3%
Net Income
764
Net Margin
18.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,117
EBITDA Margin
27.3%

2022

12/31/2022

Revenue
4,107
Cost of Revenue
1,152
Gross Profit
2,954
Gross Margin
71.9%
Operating Income
901
Operating Margin
21.9%
Net Income
809
Net Margin
19.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,151
EBITDA Margin
28.0%

2021

12/31/2021

Revenue
3,563
Cost of Revenue
861
Gross Profit
2,702
Gross Margin
75.8%
Operating Income
798
Operating Margin
22.4%
Net Income
717
Net Margin
20.1%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
984
EBITDA Margin
27.6%

2020

12/31/2020

Revenue
3,066
Cost of Revenue
769
Gross Profit
2,297
Gross Margin
74.9%
Operating Income
668
Operating Margin
21.8%
Net Income
634
Net Margin
20.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
885
EBITDA Margin
28.9%